🇺🇸 FDA
Pipeline program

Cyclobenzaprine HCl

23-0711

Phase 2 small_molecule active

Quick answer

Cyclobenzaprine HCl for Acute Stress Reaction is a Phase 2 program (small_molecule) at Tonix Pharmaceuticals Holding with 1 ClinicalTrials.gov record(s).

Program details

Company
Tonix Pharmaceuticals Holding
Indication
Acute Stress Reaction
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials